European stocks rise on optimism about coronavirus vaccine – Yahoo Finance
European stocks climbed on Wednesday as investors assessed positive results from initial trials of an experimental coronavirus vaccine produced by biotechnology firm Moderna (MRNA).
The potential vaccine, developed by researchers at the US National Institute of Allergy and Infectious Diseases, provoked a promising immune response and appeared safe in 45 healthy volunteers in an early-stage study.
The pan-European STOXX 600 index (^STOXX) rose by around 1.2%, while London’s FTSE 100 (^FTSE) climbed by almost 1%.
Germany’s DAX (^GDAXI) was up by around 1.2%, while France’s CAC 40 (^FCHI) climbed by almost 1.6%.
The data from the Moderna trial built on earlier promising, but incomplete, results the company had released in May. A late-stage trial of the vaccine candidate is set to begin on 27...